STIL Endows Oncogenic and Stem-Like Attributes to Colorectal Cancer Plausibly by Shh and Wnt Signaling

Area of Science:

• Oncology
• Molecular Biology
• Cancer Genetics

Background:

• STIL is an oncogene with an unknown role in colorectal cancer (CRC) pathogenesis.
• Understanding STIL's molecular targets is crucial for developing new CRC therapies.

Purpose of the Study:

• To investigate the role of STIL in colorectal cancer tumorigenesis.
• To identify STIL's molecular targets associated with stemness and drug resistance in CRC.

Main Methods:

• STIL gene silencing was performed in in-vitro and in-vivo CRC models.
• Expression of stemness markers (CD133, CD44) and drug resistance markers (thymidylate synthase, ABCB1, ABCG2) was analyzed.
• Correlation between STIL mRNA expression and patient survival was assessed.

Main Results:

• STIL silencing significantly reduced CRC cell proliferation and tumor growth.
• STIL regulates key stemness markers (CD133, CD44) and drug resistance genes (thymidylate synthase, ABCB1, ABCG2).
• High STIL mRNA expression correlated with reduced disease-free survival in CRC patients.
• STIL regulates beta-catenin via p-AKT, independent of the Sonic hedgehog (Shh) pathway.

Conclusions:

• STIL plays a critical role in colorectal cancer progression and molecular manifestation.
• STIL is a potential therapeutic target for overcoming drug resistance and improving outcomes in CRC.
• STIL's regulation of stemness and drug resistance markers occurs, in part, independently of the Shh pathway.